Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -17.45% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -24.47%. Over the past 30 days, the price of AMGN has leaped by -9.21%. And in the last five days, it has fallen by -3.31%.
The current stock price for Amgen Inc. (AMGN) is $216.81. The stock experienced a significant increase during the last trading session, reaching $225.96 after opening at $225.64. It dipped to a low of $221.04 before ultimately closing at $221.32.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The stock market performance of Amgen Inc. has been fairly unsteady. Over the last year, the company’s stock hit its highest at $296.67 on 11/08/22, while the lowest price during the same time frame was $220.44, recorded on 05/25/23.
52-week price history of AMGN Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Amgen Inc.’s current trading price is -26.92% away from its 52-week high, while its distance from the 52-week low is -1.65%. The stock’s price range over this timeframe has been between $220.44 and $296.67. The shares of the Healthcare sector company recorded a trading volume of approximately 0.73 million for the day, which was comparatively lower than the average daily volume of 2.24 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Amgen Inc. (AMGN) has experienced a quarterly decline of -7.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 118.69B and boasts a workforce of 25200 employees.
Expert Opinions: Analysts’ Ratings for Amgen Inc.
As of right now, 9 analysts are rating Amgen Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 14 analysts are recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 242.69, with a change in price of -45.84. Similarly, Amgen Inc. recorded 2,313,291 in trading volume during the last 100 days, posting a change of -17.45%.
AMGN’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for AMGN stands at 11.52. Similarly, the long-term debt-to-equity ratio is also 11.36.
AMGN Stock Stochastic Average
The raw stochastic average for Amgen Inc. over the last 50 days is presently at 0.43%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 0.69%. Further, the company’s Stochastic %K and %D values for the last 20 days were 7.41% and 11.08%, respectively.
